Meet an impressive Key Note speaker at our annual conference on May 26-28 in beautiful Montreux. We are particularly proud to have secured Ed Saltzman as Key Note speaker.
It is no exaggeration to say that Ed’s analysis and outlook for the pharma and biotech business development over the past two decades have had a truly significant impact on dealmaking strategies in our industry. We are very excited that Ed is honouring us with the inaugural presentation of his latest insights, entitled ¨Biopharma dealmaking: Time for a Rethink?¨
Ed is a Senior Strategic Advisor for Lumanity. He is the founder of Defined Health, one of the premier strategy advisories in biopharma and one of the earliest to focus their efforts on the emerging biotech sector. After having led the sale of Defined Health to Cello Health in 2017, Ed took on the role of Executive Chairman of Cello’s biotech business unit. Ed possesses a vast knowledge of the pharmaceutical and biotechnology industry accumulated over Defined Health’s 25+ years of consultancy to pharma, biotech, specialty pharma and investors.
Please register here to attend our conference and meet and hear from Ed: